Accendra Health, Inc. (ACH) SEC Filings & Earnings Calls

Delisting risk if stock price remains below $1.00; cure period six months; reverse stock split considered.

“NYSE notice of non-compliance with Section 802.01C; average closing price <$1.00 over 30 days.”

No ATM program reduces potential dilution but also limits equity financing flexibility.

“Company has determined that it is in the best interest of stakeholders not to put in place an at-the-market issuance program.” · word for word

CEO retirement creates leadership uncertainty during turnaround.

“CEO Ed Pesicka announces retirement by end of 2026; succession process ongoing.”

Continued losses and negative free cash flow strain liquidity.

“GAAP loss from continuing ops $(89.1)M; free cash flow $(25.1)M in Q2 2026.”

Revenue decline from commercial payor exit may persist.

“Revenue down 10% YoY; payor exit behind but impact still felt.”

CEO retirement creates leadership vacuum during critical turnaround phase.

“CEO Ed Pesicka retiring by end of 2026; succession process ongoing.”

Potential ownership change risk that could impair NOLs; plan may deter activist or strategic investors.

“The Tax Asset Preservation Plan is intended to reduce the likelihood of such an 'ownership change' under Section 382 of the Code by deterring any person or group from acquiring beneficial ownership of 4.9% or more of the Company’s outstanding common stock.” · word for word

Payor concentration risk

“A commercial Payor, with which we had multiple separately managed contracts, has terminated certain of our contracts with them.” · word for word

High leverage and refinancing risk

“Interest expense, net increased 32.8% for the three months ended June 30, 2026 compared to the prior year period.”

Negative free cash flow

“Free cash flow (non-GAAP) $(25,103) for the three months ended June 30, 2026.” · word for word

Exchange offers may indicate financial distress or need to restructure debt; lack of detail on terms.

“Exchange Offers and Consent Solicitations” · word for word

Increased leverage and interest burden from high-coupon secured notes issuance.

“Issuance of 9.000% first-lien and 9.750% second-lien notes, exchange for lower-coupon existing notes.”

Risk of not completing exchange offers; financial condition could be materially adversely affected.

“If the Company is unable to complete the Offers... its financial condition could be materially adversely affected.” · word for word

Balance sheet optimization indicates prior leverage concerns; execution risk on separation from Owens & Minor.

“announced a more than $1.5 billion comprehensive balance sheet optimization transaction with commitments from existing creditors that will strengthen the balance sheet, significantly extend maturities and reduce total leverage.” · word for word

Payor concentration risk

“A commercial Payor, with which we have multiple separately managed contracts, has terminated, or is in the process of terminating, certain of our contracts with them.” · word for word

Liquidity risk

“We have received commitments from existing creditors to exchange and/or extend a substantial portion of our debt, which would extend the maturity of these obligations beyond twelve months from the balance sheet date.” · word for word

Debt covenant compliance risk

“The Revolving Credit Agreement, the Credit Agreement, the Amended Receivables Sale Program, the 2029 Unsecured Notes, and the 2030 Unsecured Notes contain cross-default provisions which could result in the acceleration of payments due in the event of default of any of the related agreements.” · word for word

High financial distress: debt restructuring with 9%+ coupons, covenant relief, and backstop fees.

“9.000% Senior Secured First Lien Notes; 9.750% Senior Secured Second Lien Notes; consent to eliminate covenants; backstop fee of 3.50%.” · word for word

Underperformance Relative to Financial Goals

“the Company underperformed relative to the total-company financial goals set for the year, and the OP&C Committee’s compensation decisions reflect that reality.” · word for word

High Leverage / Debt Increase

“Total debt increased by $209 million” · word for word

Terminated Acquisition of Rotech

“the termination of the Company’s intended acquisition of Rotech” · word for word

Challenging Macroeconomic Environment

“a challenging macroeconomic environment” · word for word

Payor concentration and contract termination

“The terminated contracts reflected $322 million or 12% of our net revenue, including $231 million of capitation revenue, which represents nearly all of our capitation revenue, for the year ended December 31, 2025.” · word for word

Supplier concentration

“During the year ended December 31, 2025, our three largest suppliers contributed 16%, 14% and 11% of our purchases collectively accounting for approximately 40%.” · word for word

Goodwill impairment risk

“Goodwill impairment charge relates to a non-cash goodwill impairment charge recognized in the Apria reporting unit during the quarter ended December 31, 2024.” · word for word

Transition period after P&HS sale; separation from Owens & Minor pending; execution risk in becoming standalone company.

“The next several months will be a period of transition as we work towards completing the separation from Owens & Minor” · word for word

FY2026 revenue guidance implies decline from FY2025 continuing ops revenue, indicating potential loss of scale.

“Revenue ranging between $2.55 billion and $2.65 billion vs FY2025 $2.76B” · word for word

Sale of P&HS business reduces revenue base but provides cash for deleveraging and focus.

“Sale of P&HS business for $375M cash, entry into $150M receivables sale program”

CHRO departure and role elimination may signal cost-cutting or restructuring, but no financial impact disclosed.

“Jennifer Stone leaving Dec 31, 2025; CHRO role eliminated.”

Sale process risks; separation costs up to $65M; supplier guarantees up to $115M.

“Deal terms include up to $115M supplier guarantees and $65M cash separation costs.”

Commercial payor contract termination

“The terminated contracts reflected $242 million or 12% of our net revenue, including $173 million of capitation revenue, which represents nearly all of our capitation revenue, for the nine months ended September 30, 2025.” · word for word

CMS reimbursement rule change for NIPPV

“In June 2025, CMS released a final national coverage determination for non-invasive positive pressure ventilation (NIPPV) in the home for the treatment of chronic respiratory failure due to chronic obstructive pulmonary disease (COPD). This determination may make qualifying for NIPPV more difficult for new COPD patients seeking this treatment” · word for word

Execution risk from P&HS segment sale

“Unanticipated developments, including disruptions to our business due to macro-economic factors or otherwise, market conditions, the uncertainty of the financial markets, changes in the law, could delay or prevent the sale of the P&HS segment.” · word for word

High leverage and liquidity pressure

“Net cash (used for) provided by: Operating activities $ (169,976) $ 90,494” · word for word

GAAP loss from continuing operations

“(Loss) income from continuing operations, net of tax, GAAP $(5.6) million” · word for word